Park Hye-Sung, Cho Jae-Heung, Kim Koh-Woon, Chung Won-Seok, Song Mi-Yeon
Department of Korean Rehabilitation Medicine, College of Korean Medicine, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 130-701, Republic of Korea.
Evid Based Complement Alternat Med. 2018 May 15;2018:2719794. doi: 10.1155/2018/2719794. eCollection 2018.
To determine the antiobesity effects of in animals.
We conducted a systematic search for all controlled trials (up to March 2017) that assessed the antiobesity effects of in animal obesity models in the PubMed, EMBASE, Cochrane library, Web of Science, and Scopus databases. The primary outcome was final body weight measured at the longest follow-up time after administration of the intervention. The secondary outcome was the lipid profile. We assessed methodological quality using the SYRCLE risk of bias tool, and RevMan 5.3 was used to perform a meta-analysis. Finally, a subgroup analysis of parameters including intervention duration, animal models, and type of ginseng was performed.
We identified 16 studies that met the inclusion criteria. Data from the meta-analysis indicated that the intervention group had a significantly lower body weight than the control group (SMD: -1.50, 95% CI: -1.90 to -1.11, : 78.14, < 0.0001, = 58%). Final body weight was lower in an animal obesity model induced by high-fat diet than in genetic models. Also the intervention group had a significantly higher serum HDL level and lower serum LDL, TG, and TC level than the control group.
Our meta-analysis indicated that oral administration of significantly inhibits weight gain and improves serum lipid profiles in animal obesity models. However, causes of obesity and type of ginseng may affect treatment effects.
确定[具体物质]在动物体内的抗肥胖作用。
我们在PubMed、EMBASE、Cochrane图书馆、Web of Science和Scopus数据库中系统检索了所有评估[具体物质]在动物肥胖模型中抗肥胖作用的对照试验(截至2017年3月)。主要结局是在给予干预后最长随访时间测量的最终体重。次要结局是血脂谱。我们使用SYRCLE偏倚风险工具评估方法学质量,并使用RevMan 5.3进行荟萃分析。最后,对包括干预持续时间、动物模型和人参类型等参数进行亚组分析。
我们确定了16项符合纳入标准的研究。荟萃分析数据表明,干预组的体重显著低于对照组(标准化均数差:-1.50,95%置信区间:-1.90至-1.11,I²:78.14,P<0.0001,Heterogeneity=58%)。高脂饮食诱导的动物肥胖模型中的最终体重低于遗传模型。此外,干预组的血清高密度脂蛋白水平显著高于对照组,血清低密度脂蛋白、甘油三酯和总胆固醇水平低于对照组。
我们的荟萃分析表明,口服[具体物质]可显著抑制动物肥胖模型中的体重增加并改善血脂谱。然而,肥胖原因和人参类型可能会影响治疗效果。